Status:

COMPLETED

Evaluation of Gynecological Acceptability of 3 Health Care Products

Lead Sponsor:

Herbarium Laboratorio Botanico Ltda

Conditions:

Atrophic Vaginitis

Vaginal Disease

Eligibility:

FEMALE

18-70 years

Phase:

NA

Brief Summary

The research was conduct with 3 different products for use in the intimate region in up to 70 research participants, that use the investigational product by 35 ± 2 days. The subjects were follow up th...

Detailed Description

At this study, 70 female participants, 18 to 70 years, healthy with complaints of vaginal dryness used the 3 investigational product, each one by 9 days. Between the changes of product use, there were...

Eligibility Criteria

Inclusion

  • Health volunteers
  • Non-injured mucosa in the test region;
  • Agreement to adhere to study procedures and requirements and attend the institute on the day(s) and time(s) determined for the evaluations;
  • Ability to consent to their participation in the study;
  • Age from 18 to 70 years old;
  • Female participants;
  • Vaginal dryness (slight minimum) - according to questions from the gynecologist.

Exclusion

  • Pregnancy or breastfeeding;
  • Skin pathology in the area of application of the product;
  • Diabetes Mellitus type 1; insulin-dependent diabetes; presence of complications due to diabetes (retinopathy, nephropathy, neuropathy); presence of diabetes-related dermatoses (plantar ulcer, lipoid necrobiosis, annular granuloma, opportunistic infections); history of episodes of hypoglycemia, diabetic ketoacidosis and/or hyperosmolar coma;
  • Current use of the following medications for topical or systemic use:
  • corticosteroids, immunosuppressants and antihistamines;
  • Skin diseases: vitiligo, psoriasis, lupus, atopic dermatitis;
  • History of reaction to the category of the tested product;
  • Other diseases or medications that may directly interfere with the study or endanger the health of the research participant.

Key Trial Info

Start Date :

November 6 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 21 2020

Estimated Enrollment :

65 Patients enrolled

Trial Details

Trial ID

NCT04327947

Start Date

November 6 2019

End Date

February 21 2020

Last Update

April 3 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Allergisa Pesquisa Dermato-Cosmética Ltda

Campinas, Brazil